I ran an RNAseq with Brugia malayi worms treated with a drug and untreated. I found a certain number of genes differentially expressed in the treated worms as compared to the untreated. I selected one upregulated gene to conduct confirmatory qPCR. I have selected Actin to be my control for the study as its expression is unaltered. Should I consider the spliced version of the gene to build the primers or unspliced version which has the intron? The aim is to not amplify the background genomic DNA. Many literature articles say use exon-exon span to design primers. What does this mean exactly?